MOF-derived chalcogenides multifunctional heterostructure materials for high-performance supercapacitor and oxygen evolution reaction catalytic activity
Journal of Materials Chemistry A · 2026 · 14 (30) · 19518-19533
DOI: 10.1039/d6ta01424k ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry A, 2026. Verfasst von Muhammad Nasir Hussain und 6 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: İnönü Üniversitesi.
Abstract (Originalsprache)
The synthesized composites are investigated for supercapacitor and oxygen evolution reaction applications. The Cu 2 S/ZnS/CoS 2 @NPC shows the specific capacitance of 1206 F g −1 at 1 A g −1 , outperforming both the Cu/Zn/Co@NPC and Cu 2 Se/ZnSe/CoSe 2 @NPC.
Förderung
- İnönü Üniversitesi
Zitieren
APA
Hussain, M. N., Bugday, N., Hickey, S. G., Shamraiz, U., Howard, C. A., Ji, X., & Yaşar, S. (2026). MOF-derived chalcogenides multifunctional heterostructure materials for high-performance supercapacitor and oxygen evolution reaction catalytic activity. Journal of Materials Chemistry A, 14(30), 19518-19533. https://doi.org/10.1039/d6ta01424k
Vancouver
Hussain MN, Bugday N, Hickey SG, Shamraiz U, Howard CA, Ji X, et al. MOF-derived chalcogenides multifunctional heterostructure materials for high-performance supercapacitor and oxygen evolution reaction catalytic activity. Journal of Materials Chemistry A. 2026;14(30):19518-19533. doi:10.1039/d6ta01424k
BibTeX
@article{Hussain2026,
author = {Hussain, Muhammad Nasir and Bugday, Nesrin and Hickey, Stephen G. and Shamraiz, Umair and Howard, Christopher A. and Ji, Xiaobo and Yaşar, Sedat},
title = {MOF-derived chalcogenides multifunctional heterostructure materials for high-performance supercapacitor and oxygen evolution reaction catalytic activity},
journal = {Journal of Materials Chemistry A},
year = {2026},
volume = {14},
number = {30},
pages = {19518--19533},
doi = {10.1039/d6ta01424k}
}
EUVIMED